Patient-specific multi-omics models and the application in personalized combination therapy

August John, Bo Qin, Krishna R. Kalari, Liewei Wang, Jia Yu

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


The rapid advancement of high-throughput technologies and sharp decrease in cost have opened up the possibility to generate large amount of multi-omics data on an individual basis. The development of high-throughput -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics and microbiomics, enables the application of multi-omics technologies in the clinical settings. Combination therapy, defined as disease treatment with two or more drugs to achieve efficacy with lower doses or lower drug toxicity, is the basis for the care of diseases like cancer. Patient-specific multi-omics data integration can help the identification and development of combination therapies. In this review, we provide an overview of different -omics platforms, and discuss the methods for multi-omics, high-throughput, data integration, personalized combination therapy.

Original languageEnglish (US)
Pages (from-to)1737-1750
Number of pages14
JournalFuture Oncology
Issue number23
StatePublished - Aug 2020


  • Data integration
  • High-throughput
  • Multi-omics
  • Personalized combination therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Patient-specific multi-omics models and the application in personalized combination therapy'. Together they form a unique fingerprint.

Cite this